Slide 1Hepatitis B & Hepatitis C in HIV Dr K.Bujji Babu, MD Consultant HIV Physician Dr.Bujjibabu HIV Clinic. Slide 2 HIV Hepatitis B 40 million worldwide 1 million in…

Slide 1Adherence in TLC+: The Sticky Wicket Michael S. Saag, MD Center for AIDS Research University of Alabama at Birmingham USA Slide 2 One Mans Journey to Adherence: Michael…

Slide 1Management of ARV 6th Advanced HIV Course, Montpellier, September 3-5, 2008 Jürgen Rockstroh, Department of Medicine I, University of Bonn, Germany Slide 2 Natural…

Slide 1HIV/AIDS HIV destroys CD4+ cells leading to suppression of cell-mediated immunity opportunistic pathogens Pneumocystis carinii Microsporidia increased disease severity…

Slide 1 Yumi Lee, PharmD, BCPS NYSCHP- Royal Counties September 14, 2011 Slide 2  Identify the CD4 cell parameters where initiation of therapy is appropriate  Recognize…

Slide 1 Chemokine Receptor 5 Inhibition Prevents SIV-associated Cardiac Dysfunction Katie Kelly Brennan, DVM Johns Hopkins University School of Medicine Department of Molecular…

Slide 1 Accelerating Anti-Retroviral Treatment as a catalytic action for Ending AIDS Pride Chigwedere, MD, PhD Senior Advisor to the African Union AWA CONSULTATIVE EXPERTS’…

Slide 1 1 Using Biostatistics to Evaluate Vaccines and Medical Tests Holly Janes Fred Hutchinson Cancer Research Center Slide 2 2 Two projects Evaluating a candidate HIV…

Slide 1 Coinfection with Hepatitis B and HIV Chia C. Wang Assistant Professor of Medicine AIDS Clinical Conference February 20, 2007 Slide 2 Outline Epidemiology and Natural…

Slide 1 Safety and efficacy of maraviroc in CCR5-tropic HIV-1-infected children aged 2 to Methods Subjects infected with CCR5-tropic HIV-1 (as detected by Phenotypic assay,…